While we wait: there was a “fantasy” post on FB today that speculated CYDY management is considering options which includes calculating value. They noted a buy out by JNJ could give 1/2 JNJ share ($83, JNJ is also paying $4/share) for each cydy share noting that the covid revenue alone would justify such a deal.

Nader did say he had big pharma waiting for the data.

PS: please do not PM me with everything Nader has said that hasn’t come to fruition.